International trade · 09/06/2006

Novo Nordisk Files Complaint with U.S. International Trade Commission Over Insulin Delivery Devices

Novo Nordisk has filed a complaint with the U.S. International Trade Commission alleging that certain insulin delivery devices infringe on its patent, prompting the Commission to launch an investigation into the matter